Company: SNWV
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001628280-25-023881
Chunk: 24

Company: SANUWAVE Health, Inc.
Filing Date: 2025-05-08
Form: 10-Q
Item: Part I, Item 1
Chunk 24
---
IDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT

(UNAUDITED)

(In thousands, except share data)

Three Months Ended March 31, 2025Common StockNumber ofSharesIssued andOutstandingPar ValueAdditional Paid-in CapitalAccumulated Deficit Accumulated Other Comprehensive Loss Total Balances as of December 31, 20248,543,686$9 $238,685 $(251,421)$10 $(12,717)Stock-based compensation4,787- 1,101 - - 1,101 Net loss-- - (5,676)- (5,676)Balances as of March 31, 20258,548,473$9 $239,786 $(257,097)$10 $(17,292)

Three Months Ended March 31, 2024Common StockNumber ofSharesIssued andOutstandingPar ValueAdditional Paid-in CapitalAccumulatedDeficit  Accumulated Other Comprehensive Loss Total Balances as of December 31, 20233,041,492$3 $176,979 $(220,049)$(111)$(43,178)Foreign currency translation adjustment-- - - 111 111 Net loss-- - (4,528)- (4,528)Balances as of March 31, 20243,041,492$3 $176,979 $(224,577)$- $(47,595)

* Reflects a one-for-three hundred seventy-five (1:375) reverse stock split of the outstanding shares of the Company's common stock effected on October 18, 2024.

The accompanying notes to condensed consolidated financial statements are an integral part of these financial statements.

6

SANUWAVE HEALTH, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

Three Months Ended March 31,(in thousands)20252024Cash Flows - Operating Activities:Net loss$(5,676)$(4,528)Adjustments to reconcile net loss to net cash used by operating activitiesStock-based compensation975 - Depreciation and amortization209 136 Amortization of right to use leases65 82 Reserve for credit losses33 147 Loss on extinguishment of debt- 105 Change in fair value of derivative liabilities4